Skin cancer referrals have nearly tripled over the last decade [1]. At the same time, 1 in 4 Consultant Dermatologist posts remain unfilled [2]. Despite sustained and considerable effort from dermatology departments, waitlists have doubled over the last half-decade and over 400,000 patients are waiting to be seen [3].
Skin Analytics’ Class III CE marked AI as a Medical Device (AIaMD), DERM (Deep Ensemble for the Recognition of Malignancy), is built around our custom built teledermatology platform to help triage patients into the right place, at the right time and to conserve dermatologist capacity for patients who need it.
DERM safely triages patients with non-cancerous lesions away from cancer pathways, allowing dermatologists to focus on the patients that need them most.
Skin Analytics deploys the only use of autonomous AI for dermatology in the NHS
Our latest quarterly report showed
appropriate ruling out of melanoma and
benign lesion biopsies can be prevented
In NHS Primary Care, DERM typically avoids urgent suspected cancer referrals for up to
of patients with 40-55% discharged
Skin Analytics has helped Secondary Care organisations avoid up to
of NHS face-to-face USCRs by combining DERM with downstream teledermatology reviews where patients can be routed straight to biopsy
Skin Analytics has 25 partners using DERM across the NHS
If you would like to know more about how Skin Analytics can help you and your dermatology team deliver best in class dermatology, get in touch.
